AU583553B2 - Plipastatin and method for preparation thereof - Google Patents

Plipastatin and method for preparation thereof

Info

Publication number
AU583553B2
AU583553B2 AU50307/85A AU5030785A AU583553B2 AU 583553 B2 AU583553 B2 AU 583553B2 AU 50307/85 A AU50307/85 A AU 50307/85A AU 5030785 A AU5030785 A AU 5030785A AU 583553 B2 AU583553 B2 AU 583553B2
Authority
AU
Australia
Prior art keywords
plipastatin
ala
val
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50307/85A
Other languages
English (en)
Other versions
AU5030785A (en
Inventor
Takaaki Aoyagi
Masa Hamada
Yasuhiko Muraoka
Hiroshi Naganawa
Takaaki Nishikiori
Tomio Takeuchi
Hamao Umezawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of AU5030785A publication Critical patent/AU5030785A/en
Application granted granted Critical
Publication of AU583553B2 publication Critical patent/AU583553B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
AU50307/85A 1984-12-06 1985-11-25 Plipastatin and method for preparation thereof Ceased AU583553B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59-256475 1984-12-06
JP59256475A JPS61134398A (ja) 1984-12-06 1984-12-06 新生理活性物質プリパスタチン及びその製造法

Publications (2)

Publication Number Publication Date
AU5030785A AU5030785A (en) 1986-06-12
AU583553B2 true AU583553B2 (en) 1989-05-04

Family

ID=17293148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50307/85A Ceased AU583553B2 (en) 1984-12-06 1985-11-25 Plipastatin and method for preparation thereof

Country Status (13)

Country Link
US (1) US4742155A (enExample)
EP (1) EP0192828B1 (enExample)
JP (1) JPS61134398A (enExample)
KR (1) KR920006881B1 (enExample)
AT (1) ATE63318T1 (enExample)
AU (1) AU583553B2 (enExample)
DE (1) DE3582791D1 (enExample)
DK (1) DK564785A (enExample)
ES (1) ES8701197A1 (enExample)
GR (1) GR852894B (enExample)
HU (1) HU193838B (enExample)
PT (1) PT81615B (enExample)
ZA (1) ZA859315B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
IN167138B (enExample) * 1988-08-17 1990-09-01 Hoechst India
US5619066A (en) * 1990-05-15 1997-04-08 Dallas Semiconductor Corporation Memory for an electronic token
JPH07500814A (ja) * 1991-07-04 1995-01-26 ガーヴァン インスティチュート オブ メディカル リサーチ Ｐｌａ２阻害性化合物
CN1255143A (zh) * 1997-05-09 2000-05-31 阿格拉奎斯特公司 控制植物疾病和黄瓜十二星叶甲的芽孢杆菌新型菌株
CN117683074B (zh) * 2023-12-13 2024-08-16 山东绿邦生物科技有限公司 蜡样芽孢杆菌、蛋白酶抑制剂以及提高蛋白渣产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F

Also Published As

Publication number Publication date
PT81615B (pt) 1988-02-17
AU5030785A (en) 1986-06-12
HU193838B (en) 1987-12-28
HUT40707A (en) 1987-01-28
EP0192828B1 (en) 1991-05-08
GR852894B (enExample) 1986-04-01
EP0192828A3 (en) 1988-06-01
PT81615A (en) 1986-01-01
DK564785A (da) 1986-06-07
JPS61134398A (ja) 1986-06-21
KR860005027A (ko) 1986-07-16
ES8701197A1 (es) 1986-11-16
US4742155A (en) 1988-05-03
DK564785D0 (da) 1985-12-05
ATE63318T1 (de) 1991-05-15
EP0192828A2 (en) 1986-09-03
KR920006881B1 (ko) 1992-08-21
ES549565A0 (es) 1986-11-16
DE3582791D1 (de) 1991-06-13
ZA859315B (en) 1986-10-29

Similar Documents

Publication Publication Date Title
Booth et al. Metabolism of polycyclic compounds. 15. The conversion of naphthalene into a derivative of glutathione by rat-liver slices
AU4385785A (en) Substituted bicyclic compounds
KR900017580A (ko) 표피 성장 인자를 함유하는 안정화된 조성물
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
ES8703472A1 (es) Procedimiento para preparar nuevos derivados imidazo
AU5030785A (en) Plipastatin and method for preparation thereof
le Pape et al. Modifications of glomerular basement membrane cross-links in experimental diabetic rats
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
PT82815B (pt) Processo de preparacao de derivados da imidazolidina, dos seus sais farmaceuticamente aceitaveis e das composicoes farmaceuticas que os contem
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
ES516694A0 (es) Procedimiento de preparacion de derivados de la 4-fenil quinazolina.
Murphy et al. The turnover catabolism and excretion of folate administered at physiological concentrations in the rat
PT75385B (en) Process for the preparation of aminoglycosides derivatives and of compositions containing these derivatives
RU94018525A (ru) Замещенные 2-гидрокси-3[1-(1н-имидазол-4-ил)алкил]-бензолкарбоксимидамиды, способы их получения и фармацевтическая композиция на их основе
EP0156063A3 (en) Hypoglycaemic tetrapeptides
Van Zyl et al. A spray method for the simultaneous detection of iodide and iodinated amino-acids on filter paper chromatograms
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
EP0257418A3 (en) Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
ZA902167B (en) Thienylpiperazines,process for the preparation thereof,the use thereof,and pharmaceuticals containing these and the preparation thereof
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
MD675C2 (ro) Complecşi ai cobaltului cu acţiune antimicrobiană şi procedeu de obţinere a lor
NO871720L (no) Oxyalkylcellulose-holdig gelmateriale.
AU4166389A (en) Salt of 6-piperidino-2,4-diaminopyrimidine 3-oxide and aceturic acid, its preparation and its dermatocosmetilogical application
PL247504A1 (en) Process for preparing novel 4-chlorophenoxyacetate